share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144:拟议出售证券
美股sec公告 ·  04/19 10:44
Moomoo AI 已提取核心信息
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 04/19/2024, as per the latest filing. These shares, valued at an aggregate market value of $3,624.76, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered. This upcoming transaction follows a significant trading activity by Austin over the past three months, where a total of 249,984 shares were sold, amounting to gross proceeds of $302,693.73. The notice for the planned sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 04/19/2024, as per the latest filing. These shares, valued at an aggregate market value of $3,624.76, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered. This upcoming transaction follows a significant trading activity by Austin over the past three months, where a total of 249,984 shares were sold, amounting to gross proceeds of $302,693.73. The notice for the planned sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.
最新文件显示,Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年4月19日出售3,968股A类股票。这些股票的总市值为3,624.76美元,最初于2022年7月10日作为限制性股票归属的一部分收购,是对所提供服务的补偿。这笔即将进行的交易是在奥斯汀在过去三个月中进行了大量交易活动之后进行的,共出售了249,984股股票,总收益为302,693.73美元。计划出售的通知与出售的同一天提交,该交易的计划已于2023年3月14日获得通过。
最新文件显示,Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年4月19日出售3,968股A类股票。这些股票的总市值为3,624.76美元,最初于2022年7月10日作为限制性股票归属的一部分收购,是对所提供服务的补偿。这笔即将进行的交易是在奥斯汀在过去三个月中进行了大量交易活动之后进行的,共出售了249,984股股票,总收益为302,693.73美元。计划出售的通知与出售的同一天提交,该交易的计划已于2023年3月14日获得通过。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息